Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
High Active Antiretroviral Combination Drugs Loaded Lactoferrin Nanoparticles For First Line And Second Line Therapy
Abstract: The present invention relates to preparation and characterization of HAART combination 655 anti-retroviral drugs loaded lactoferrin nanoparticles for first line and second line therapy. The first line drug combination is Zidovudine (AZT), Efavirenz (EFV) and Lamivudine (LMV) and the second line drug combination is Tenofovir (TNF), Lamivudine (LMV) and Atazanavir (ATV) / Ritonavir (r). The formulated drugs are especially suitable to be administered orally. The nanoformulation enhances anti-HIV activity of drugs along with 660 significant decrease in drug-related toxicity and improvement in bioavailability and PK profile of the drugs.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
03 May 2016
Publication Number
45/2017
Publication Type
INA
Invention Field
PHARMACEUTICALS
Status
Email
patents@eevatech.com
Parent Application
Patent Number
Legal Status
Grant Date
2021-12-01
Renewal Date
Applicants
UNIVERSITY OF HYDERABAD
GACHIBOWLI, HYDERABAD - 500 046.
Inventors
1. ANAND KUMAR KONDAPI
DEPARTMENT OF BIOTECHNOLOGY AND BIOINFORMATICS SCHOOL OF LIFE SCIENCES, UNIVERSITY OF HYDERABAD, GACHIBOWLI, HYDERABAD - 500 046.
Specification
DESC:as attached ,CLAIMS:as attached
Documents
Orders
| Section | Controller | Decision Date |
|---|---|---|
| u/s 15 | R HEMALATHA | 2021-07-29 |
| u/s 15 | R HEMALATHA | 2021-12-01 |
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 201641015363-Other Patent Document-030516.pdf | 2016-05-31 |
| 2 | 201641015363-Form 5-030516.pdf | 2016-05-31 |
| 3 | 201641015363-Form 3-030516.pdf | 2016-05-31 |
| 4 | 201641015363-Form 26-030516.pdf | 2016-05-31 |
| 5 | 201641015363-Form 2(Title Page)-030516.pdf | 2016-05-31 |
| 6 | 201641015363-Form 1-030516.pdf | 2016-05-31 |
| 7 | OTHERS [16-07-2016(online)].pdf | 2016-07-16 |
| 8 | Drawing [16-07-2016(online)].pdf | 2016-07-16 |
| 9 | Description(Complete) [16-07-2016(online)].pdf | 2016-07-16 |
| 11 | Form-2(Online).pdf | 2016-09-30 |
| 12 | Form 18 [24-05-2017(online)].pdf | 2017-05-24 |
| 13 | 201641015363-RELEVANT DOCUMENTS [19-04-2021(online)].pdf | 2021-04-19 |
| 14 | 201641015363-POA [19-04-2021(online)].pdf | 2021-04-19 |
| 15 | 201641015363-PETITION UNDER RULE 137 [19-04-2021(online)].pdf | 2021-04-19 |
| 16 | 201641015363-OTHERS [19-04-2021(online)].pdf | 2021-04-19 |
| 17 | 201641015363-MARKED COPIES OF AMENDEMENTS [19-04-2021(online)].pdf | 2021-04-19 |
| 18 | 201641015363-FORM 13 [19-04-2021(online)].pdf | 2021-04-19 |
| 19 | 201641015363-FER_SER_REPLY [19-04-2021(online)].pdf | 2021-04-19 |
| 20 | 201641015363-DRAWING [19-04-2021(online)].pdf | 2021-04-19 |
| 21 | 201641015363-COMPLETE SPECIFICATION [19-04-2021(online)].pdf | 2021-04-19 |
| 22 | 201641015363-CLAIMS [19-04-2021(online)].pdf | 2021-04-19 |
| 23 | 201641015363-AMMENDED DOCUMENTS [19-04-2021(online)].pdf | 2021-04-19 |
| 24 | 201641015363-ABSTRACT [19-04-2021(online)].pdf | 2021-04-19 |
| 25 | 201641015363-POA [11-06-2021(online)].pdf | 2021-06-11 |
| 26 | 201641015363-FORM-26 [11-06-2021(online)].pdf | 2021-06-11 |
| 27 | 201641015363-FORM 13 [11-06-2021(online)].pdf | 2021-06-11 |
| 28 | 201641015363-Correspondence to notify the Controller [11-06-2021(online)].pdf | 2021-06-11 |
| 29 | 201641015363-Annexure [11-06-2021(online)].pdf | 2021-06-11 |
| 30 | 201641015363-Written submissions and relevant documents [08-07-2021(online)].pdf | 2021-07-08 |
| 31 | 201641015363-Annexure [08-07-2021(online)].pdf | 2021-07-08 |
| 32 | 201641015363-Written submissions and relevant documents [27-07-2021(online)].pdf | 2021-07-27 |
| 33 | 201641015363-Annexure [27-07-2021(online)].pdf | 2021-07-27 |
| 34 | 201641015363-OTHERS [29-09-2021(online)].pdf | 2021-09-29 |
| 35 | 201641015363-EVIDENCE FOR REGISTRATION UNDER SSI [29-09-2021(online)].pdf | 2021-09-29 |
| 36 | 201641015363-US(14)-HearingNotice-(HearingDate-24-06-2021).pdf | 2021-10-17 |
| 37 | 201641015363-FER.pdf | 2021-10-17 |
| 38 | 201641015363-NBA Approval Submission [23-10-2021(online)].pdf | 2021-10-23 |
| 39 | 201641015363-NBA Approval Submission [06-11-2021(online)].pdf | 2021-11-06 |
| 40 | 201641015363-PatentCertificate01-12-2021.pdf | 2021-12-01 |
| 41 | 201641015363-IntimationOfGrant01-12-2021.pdf | 2021-12-01 |
| 42 | 201641015363-RELEVANT DOCUMENTS [17-06-2023(online)].pdf | 2023-06-17 |
| 43 | 201641015363-EVIDENCE FOR REGISTRATION UNDER SSI [30-04-2024(online)].pdf | 2024-04-30 |
| 44 | 201641015363-EDUCATIONAL INSTITUTION(S) [30-04-2024(online)].pdf | 2024-04-30 |
Search Strategy
| 1 | searchTPOE_15-10-2020.pdf |